| GTO ID | GTC0989 |
| Trial ID | ChiCTR2200058738 |
| Disease | Multiple Myeloma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | A single-arm, unblinded safety and efficacy of CAR-T therapy in patients with multiple myeloma clinical research |
| Year | 2022 |
| Country | China |
| Company sponsor | Huizhou Municipal Central Hospital |
| Cohort 1 | |||||||
|
|||||||